Related Experiment Video
Updated: May 1, 2026

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis
Published on: June 14, 2019
Human papillomavirus detection and p16INK4a expression in cervical lesions: a comparative study
Jordi Genovés1, Frances Alameda2, Gemma Mancebo3
1Department of Obstetrics and Gynecology, Hospital Universitari del Mar, 08003 Barcelona, Catalonia, Spain.
p16(INK4a) expression aids in diagnosing cervical lesions linked to high-risk human papillomavirus (HR-HPV). However, p16 negativity in low-grade lesions doesn't guarantee regression, necessitating careful diagnosis.
Area of Science:
- Gynecologic Pathology
- Oncovirology
- Biomarker Research
Background:
- p16(INK4a) expression correlates with high-risk human papillomavirus (HR-HPV) in cervical dysplasia.
- Immunohistochemical detection of p16(INK4a) can improve diagnostic reproducibility and prognostic assessment in cervical biopsies.
- Understanding p16(INK4a) expression patterns is crucial for managing cervical intraepithelial neoplasia (CIN).
Purpose of the Study:
- To investigate the immunohistochemical expression of p16(INK4a) in various grades of cervical intraepithelial neoplasia (CIN).
- To correlate p16(INK4a) expression with HR-HPV detection and genotyping in dysplastic cervical lesions.
- To evaluate the diagnostic and prognostic implications of p16(INK4a) negativity in CIN-I and CIN-II lesions.
Main Methods:
- Analysis of 86 cervical lesions (54 CIN-I, 23 CIN-II, 9 CIN-III) for p16(INK4a) expression using immunohistochemistry.
- Detection and genotyping of HR-HPV in all studied lesions.
- Follow-up assessment of p16-negative CIN-I and CIN-II cases to monitor lesion progression.
Main Results:
- HR-HPV was detected in a high percentage of CIN-II (21/23) and CIN-III (9/9) cases, and a significant proportion of CIN-I (19/54) cases.
- p16(INK4a) immunoreactivity was observed in all CIN-III cases, most HR-HPV-positive CIN-II cases, and a subset of HR-HPV-positive CIN-I cases.
- Follow-up revealed progression to high-grade lesions in some p16-negative CIN-I and CIN-II cases, indicating that p16 negativity does not always signify regression.
Conclusions:
- p16(INK4a) negativity in CIN-I and CIN-II biopsies should not be interpreted as definitive lesion regression.
- Diagnosis of CIN-II should not rely exclusively on p16(INK4a) results, emphasizing the need for comprehensive evaluation.
- p16(INK4a) remains a valuable adjunct in assessing cervical dysplasia, but its limitations in predicting regression must be acknowledged.
More Related Videos
10:26RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma
Published on: March 11, 2014
13:41Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
Published on: March 8, 2012